Correction: A multi-center, open-label, randomized study to explore efficacy and safety of baricitinib in active primary Sjogren's syndrome patients

Affiliations

• ¹ Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College; National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology; State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital; Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, 100730, China.
• ² Department of Rheumatology and Immunology, Changzheng Hospital, Naval Medical University, Shanghai, 200003, China.
• ³ Department of Rheumatology and Immunology, Tianjin Medical University General Hospital, Tianjin, China.
• ⁴ Department of Rheumatology, The Afliated Hospital of Inner Mongolia Medical University, Hohhot, Inner Mongolia, China.
• ⁵ Department of Rheumatology, Third Hospital of Shanxi Medical University, Bethune Hospital Shanxi Academy of Medical Sciences, Taiyuan, Shanxi, China.
• ⁶ Department of Rheumatology and Allergy, Xuanwu Hospital, Capital Medical University, Beijing, China.
• ⁷ Department of Rheumatology and Immunology, The First Afliated Hospital and College of Clinical Medicine, Henan University of Science and Technology, Luoyang, Henan, China.
• ⁸ Department of Rheumatology and Immunology, Tangdu Hospital, Fourth Military Medical University (Air Force Medical University), Xi'an, Shaanxi, China.
• ⁹ Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College; National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology; State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital; Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, 100730, China. xiaofeng.zeng@cstar.org.cn.
• ¹⁰ Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College; National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology; State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital; Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, 100730, China. lpumch@126.com.